# Intrathecal Dexmedetomidine With Bupivacaine, in Patients Undergoing Knee Orthopedic Surgery

> **NCT07522736** · NA · RECRUITING · sponsor: **Cairo University** · enrollment: 120 (estimated)

## Conditions studied

- Intrathecal Dexmedetomidine
- Bupivacaine
- Knee Orthopedic Surgery

## Interventions

- **DRUG:** Dexmedetomidine 4 μg
- **DRUG:** Dexmedetomidine 8 μg
- **DRUG:** Dexmedetomidine 12 μg

## Key facts

- **NCT ID:** NCT07522736
- **Lead sponsor:** Cairo University
- **Sponsor class:** OTHER
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2025-03-01
- **Primary completion:** 2026-08-30
- **Final completion:** 2026-08-30
- **Target enrollment:** 120 (ESTIMATED)
- **Last updated:** 2026-04-13


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07522736

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07522736, "Intrathecal Dexmedetomidine With Bupivacaine, in Patients Undergoing Knee Orthopedic Surgery". Retrieved via AI Analytics 2026-05-27 from https://api.ai-analytics.org/clinical/NCT07522736. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*